Cangrelor offers advantages for antiplatelet management in PCI

PARIS – Parenteral cangrelor is a potent antiplatelet agent that provides similar anti-ischemic effects but a significantly lower risk of major bleeding than the popular combination of clopidogrel...
Source: Hospitalist News - Category: Hospital Management Source Type: research